Latest Breaking News On - Disease targets - Page 1 : comparemela.com

TRIANA Biomedicines, Inc. (TRIANA), an innovative biopharmaceutical company focused on advancing a target-first and rational molecular glue discovery platform to address difficult to drug disease targets, today announced that Dr. Patrick Trojer, President and Chief Executive Officer, will present at the UBS Biotechnology Private Company Virtual Symposium on Wednesday September 20, 2023 at 3:30 PM ET.

United statesPatrick trojerBiotechnology private company virtual symposium on wednesdayBiomedicines incChief executive officerPrivate company virtual symposiumWednesday septemberIopharmaceutical companyRivate biotechnology companyDrug discoveryDisease targets